|
|
||||||||
Department of Biomolecular Chemistry, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53706-1532, USA
(RECEIVED December 22, 2005; FINAL REVISION February 2, 2006; ACCEPTED February 13, 2006)
| Abstract |
|---|
|
|
|---|
Keywords: Sir; ORC; silencing
| Introduction |
|---|
|
|
|---|
Although it is clear that Sir3p must interact with other Sir proteins to function in silencing, molecular and structural details about these interactions are lacking, and the mechanisms underlying Sir3s functions in silencing are unknown. At the level of primary structure, Sir3p is most similar to Orc1p, which has well-established roles in both DNA replication and transcriptional silencing. Orc1p is the largest subunit of the origin recognition complex (ORC), a conserved six-subunit heteromeric protein complex that binds replication origins and is essential for the initiation of DNA replication in all eukaryotes (Bell 2002). The primary role for ORC in silencing the HM loci is to bind Sir1p, a HM-specific Sir protein that, in turn, helps recruit and/or stabilize the Sir24 complex(es) at these loci (Fox and McConnell 2005). Physical association between Orc1p and Sir1p occurs between discreet domains within each protein: the ORC interaction region (OIR) of Sir1p (Bose et al. 2004) and the N-terminal bromo adjacent homology (BAH) domain of Orc1p (Zhang et al. 2002). The Orc1p BAH domain is required for Orc1p's role in silencing but is dispensable for its essential function in DNA replication (Bell et al. 1995). High-resolution crystal structures of the OIR and the Orc1pBAH domains and of the complex formed between these domains have been solved recently, providing structural insights into a proteinprotein interaction that is critical to the establishment of silent chromatin (Zhang et al. 2002; Hou et al. 2005; Hsu et al. 2005).
Sir3s significant similarity to Orc1p and its shared biological role with both Orc1p and Sir1p in silencing raise the reasonable postulate that it may also form a complex with Sir1p important for silencing. Sir3p and Orc1p are strikingly similar over their N-terminal
216 amino acids, sharing 48% identity and 67% similarity (Bell et al. 1995; Fig. 1A). However, directed two-hybrid assays under conditions that revealed the robust interaction between Sir1p and the Orc1pBAH domain failed to detect a Sir3p/Sir1p interaction (Triolo and Sternglanz 1996), and GST pull-down experiments also failed to detect a Sir3pBAH/Sir1p interaction under conditions that allowed for a robust Orc1pBAH/Sir1p interaction (Zhang et al. 2002). In addition, genetic evidence argues against a simple Sir1p-binding role for the Sir3pBAH domain in silencing. For example, Sir1p is dispensable for telomeric silencing (Fox et al. 1997), yet mutational analysis of SIR3 supports a role for the Sir3pBAH domain in telomeric silencing and for efficient HML-silencing in cells harboring a sir1
mutation (Stone et al. 2000). Together, these data support the conclusion that the Sir3pBAH domain's role in silencing does not involve interactions with the Sir1pOIR despite the intriguing and significant similarity between the Orc1p and Sir3p BAH domains.
|
| Results and Discussion |
|---|
|
|
|---|
|
-sheets that defines the BAH structural domain (Fig. 1B). Least-squares superimposition of the Sir3pBAH domain structure with that from the Orc1p reveals their highly conserved structural features (root mean square deviation [RMSD] = 1.6 Å for 180 common C
atoms; see Fig. 1C). This structural similarity is not surprising given the high level of amino acid similarity between these two protein domains (Fig. 1A). Notably, both domains contain similar extruded "H-domains," which, in the Orc1pBAH domain, forms a key portion of the essential interface with Sir1p (Hou et al. 2005; Hsu et al. 2005). The H domain is comprised of three helices (
2,
3, and
4) that are not found in other BAH domain proteins (Zhang et al. 2002). Significantly, the differences in their H-domains are sufficient for explaining the biochemical differences between the Orc1pBAH and Sir3pBAH domains in terms of binding Sir1p; a recombinant chimeric protein, in which the H-domain of Sir3p was replaced with that of Orc1p, is able to bind the C-terminal amino acids 348678 of Sir1p in a GST pull-down experiment (Zhang et al. 2002).
A more detailed examination of the surface structure of the Sir3pBAH domain, particularly regions formed by the H domain, revealed a number of molecular features that could account for these observations. First, although the H domains of the two proteins overlapped substantially (RMSD = 1.6 Å for 31 C
atoms), several amino acid differences existed between the two domains in regions known to form elements of the Orc1p/Sir1p interface (Fig. 1A, regions underlined in Orc1p). For example, in the
4 helix of Orc1pBAH, four amino acids are important for its interaction with the Sir1pOIR: N120, K121, F123, and S124. Of these four residues, only F123 is invariant between Sir3pBAH and Orc1pBAH, with substitutions of K120, D121, and F124 found in the Sir3pBAH domain (Fig. 1A). In addition, five residues E61, A62, A63, G64, and T65that comprise the loop between the
4 and
5 strands and the N terminus of
5 form another surface on Orc1p that interacts with the Sir1pOIR (Fig. 1). Of these five residues, only one, T65, is conserved in the Sir3pBAH domain. Thus, although the secondary structural features of the Sir3pBAH and Orc1pBAH domains showed remarkable similarity, there are differences in key surface residues important for forming a complex with Sir1pOIR.
A second difference that is likely to help explain biochemical differences between the BAH domains became apparent when we examined their surface representations (Fig. 2). The analogous surfaces on both protein domains formed a superficially similar overall concave surface, although the width and the depth of these regions differed somewhat (Fig. 2A,B). The high-resolution structure of the complex between the Orc1pBAH and Sir1pOIR domains indicates that such differences are likely significant; the Orc1pBAH surface that binds Sir1pOIR is highly complementary to the convex interaction surface presented by the Sir1pOIR (Hou et al. 2005; Hsu et al. 2005). A particularly striking example of this significance is provided by a major contact point between the Orc1pBAH and Sir1pOIR that is formed by the insertion of P492 from Sir1p into a deep, hydrophobic pocket on the Orc1pBAH domain formed by a cluster of six amino acids on the Orc1pBAH surface (Fig. 2B). This pocket is notably absent in Sir3pBAH (Fig. 2A). Interestingly, and in contrast to the examples discussed above, several of the amino acids in Orc1p that form this pocket are either invariant or chemically similar to the analogous amino acids in Sir3p (Fig. 2C). Specifically, W93, F94, F123, and P98 are invariant between Orc1p and Sir3p, and V96 and N120 of Orc1p are conservatively substituted with L96 and K120 in Sir3p. However, in this Sir1pOIR contact point, the single nonconservative substitution of S124 on Orc1p with F124 on Sir3p is sufficient for burying a potential binding pocket, creating instead a relatively flat surface that would prevent Sir1p P492 from inserting into the pocket (Fig. 2A). Such an effect would also preclude the rest of the Sir1pOIR interaction surface from fitting snugly into the analogous interaction surface on the Sir3 BAH domain.
|
| Materials and methods |
|---|
|
|
|---|
-D-thiogalactopyranoside for 3 h. Cells were harvested by centrifugation, frozen at 80°C, resuspended at 4°C in lysis buffer (50 mM HEPES at pH 6.5, 500 mM sodium chloride, 10% glycerol, 20 mM imidazole) supplemented with 10 µg/mL DNaseI (Sigma), and lysed by sonication on ice. The resulting extract was cleared by centrifugation (38,000g for 15 min) and incubated with Ni-NTA resin (Novagen) at 4°C for 1 h. The resin was then packed into a column and washed with 10 column volumes of lysis buffer, and (His)6Sir3pBAH was eluted with elution buffer (lysis buffer plus 500 mM Imidazole). The (His)6Sir3pBAH was buffer-exchanged into lysis buffer with 60 units of thrombin (Sigma) to remove the (His)6 N-terminal tag. The cleaved Sir3pBAHp was then flowed over a second Ni-NTA column, concentrated, and purified over a Sephacryl S-100 column (Amersham Biosciences) equilibrated with 50 mM HEPES (pH 6.5), 500 mM sodium chloride, 10% glycerol. Protein purity was determined to be >95% by SDS-PAGE. Protein concentrations were measured spectrophotometrically by measuring sample A280nm in 6.0 M Guanidine-HCl and using a calculated molar extinction coefficient of 40,090 mol1 cm1.
Crystallization and structure determination of Sir3pBAH
Purified Sir3p-BAH was concentrated to 68 mg/mL and dialyzed into 10 mM HEPES (pH 6.5), 50 mM sodium chloride. Crystals appeared spontaneously upon dialysis. To control crystal growth, Sir3pBAH was dialyzed into 400 mM ammonium acetate prior to crystallization trials. Sir3pBAH crystals formed under a variety of conditions, but final diffraction quality crystals were grown at room temperature by hanging-drop vapor diffusion mixing 1 µL of protein (6 mg/mL) with 1 µL of well solution (0.1 M HEPES at pH 6.5, 200 mM sodium chloride, 5%15% PEG 400). Crystals were transferred to cryoprotection buffer (0.1 M HEPES at pH 6.5, 200 mM sodium chloride, 30% PEG 400) before freezing in liquid nitrogen for data collection. Crystals diffracted to 1.95 Å resolution with C2 symmetry and unit cell dimensions of a = 94.6 Å, b = 44.1 Å, c = 53.7 Å,
=
= 90,
= 96.9°, consistent with one molecule of Sir3pBAH per asymmetric unit (Matthews 1968). The final structure was determined by molecular replacement using AMORE (Navaza 2001) with the Orc1pBAH structure (Zhang et al. 2002) as a search model. The molecular replacement solution was refined with REFMAC5_ARP (Winn et al. 2001) and by manually rebuilding the model with O (Jones et al. 1991).
| Footnotes |
|---|
Reprint requests to: James L. Keck or Catherine A. Fox, Department of Biomolecular Chemistry, 587 Medical Sciences Center, 1300 University Avenue, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706-1532, USA; e-mail: jlkeck{at}wisc.edu or cfox{at}wisc.edu; fax: (608) 262-5253.
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.052061006.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Bell S.P., Mitchell J., Leber J., Kobayashi R., Stillman B. 1995. The multidomain structure of Orc1p reveals similarity to regulators of DNA replication and transcriptional silencing Cell 83: 563568.[CrossRef][Medline]
Bose M.E., McConnell K.H., Gardner-Aukema K.A., Muller U., Weinreich M., Keck J.L., Fox C.A. 2004. The origin recognition complex and Sir4 protein recruit Sir1p to yeast silent chromatin through independent interactions requiring a common Sir1p domain Mol. Cell. Biol. 24: 774786.
Carmen A.A., Milne L., Grunstein M. 2002. Acetylation of the yeast histone H4 N terminus regulates its binding to heterochromatin protein SIR3 J. Biol. Chem. 277: 47784781.
Denu J.M. 2003. Linking chromatin function with metabolic networks: Sir2 family of NAD(+)-dependent deacetylases Trends Biochem. Sci. 28: 4148.[CrossRef][Medline]
Fox C.A. and McConnell K.H. 2005. Toward biochemical understanding of a transcriptionally silenced chromosomal domain in Saccharomyces cerevisiae J. Biol. Chem. 280: 86298632.
Fox C.A., Ehrenhofer-Murray A.E., Loo S., Rine J. 1997. The origin recognition complex, SIR1 and the S phase requirement for silencing Science 276: 15471551.
Hou Z., Bernstein D.A., Fox C.A., Keck J.L. 2005. Structural basis of the Sir1origin recognition complex interaction in transcriptional silencing Proc. Natl. Acad. Sci. 102: 84898494.
Hsu H.C., Stillman B., Xu R.M. 2005. Structural basis for origin recognition complex 1 proteinsilence information regulator 1 protein interaction in epigenetic silencing Proc. Natl. Acad. Sci. 102: 85198524.
Johnson L.M., Kayne P.S., Kahn E.S., Grunstein M. 1990. Genetic evidence for an interaction between SIR3 and histone H4 in the repression of the silent mating loci in Saccharomyces cerevisiae Proc. Natl. Acad. Sci. 87: 62866290.
Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard M. 1991. Improved methods for binding protein models in electron density maps and the location of errors in these models Acta Crystallogr. A 47: 110119.[CrossRef]
Liou G.G., Tanny J.C., Kruger R.G., Walz T., Moazed D. 2005. Assembly of the SIR complex and its regulation by O-acetyl-ADP-ribose, a product of NAD-dependent histone deacetylation Cell 121: 515527.[CrossRef][Medline]
Liu C. and Lustig A.J. 1996. Genetic analysis of Rap1p/Sir3p interactions in telomeric and HML silencing in Saccharomyces cerevisiae Genetics 143: 8193.[Abstract]
Matthews B.W. 1968. Solvent content of protein crystals J. Mol. Biol. 33: 491497.[Medline]
Moazed D., Rudner A.D., Huang J., Hoppe G.J., Tanny J.C. 2004. A model for step-wise assembly of heterochromatin in yeast Novartis Found. Symp. 259: 4856 [discussion 5662, 163169].[Medline]
Navaza J. 2001. Implementation of molecular replacement in AMoRe Acta Crystallogr. D Biol. Crystallogr. 57: 13671372.[CrossRef][Medline]
Rusche L.N., Kirchmaier A.L., Rine J. 2003. The establishment, inheritance, and function of silenced chromatin in Saccharomyces cerevisiae Annu. Rev. Biochem. 72: 481516.[CrossRef][Medline]
Stone E.M., Reifsnyder C., McVey M., Gazo B., Pillus L. 2000. Two classes of sir3 mutants enhance the sir1 mutant mating defect and abolish telomeric silencing in Saccharomyces cerevisiae Genetics 155: 509522.
Triolo T. and Sternglanz R. 1996. Role of interactions between the origin recognition complex and Sir1 in transcriptional silencing Nature 381: 251253.[CrossRef][Medline]
Wade P., Pruss D., Wolffe A. 1997. Histone acetylation: Chromatin in action Trends Biochem. Sci. 4: 128132.
Wang X., Connelly J.J., Wang C.L., Sternglanz R. 2004. Importance of the Sir3 N terminus and its acetylation for yeast transcriptional silencing Genetics 168: 547551.
Winn M.D., Isupov M.N., Murshudov G.N. 2001. Use of TLS parameters to model anisotropic displacements in macromolecular refinement Acta Crystallogr. D Biol. Crystallogr. 57: 122133.[CrossRef][Medline]
Zhang Z., Hayashi M.K., Merkel O., Stillman B., Xu R.M. 2002. Structure and function of the BAH-containing domain of Orc1p in epigenetic silencing EMBO J. 21: 46004611.[CrossRef][Medline]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |